03.12.2012 • News

CEO Ton Büchner Returns to AkzoNobel

The Supervisory Board of AkzoNobel is delighted to announce that CEO Ton Büchner will resume his duties on Friday, December 7, following a full recovery.

"On behalf of the Supervisory Board and the Executive Committee we welcome Ton coming back to the office. It has obviously been a testing time for all of us but now Ton is back as expected, leading the company forward and returning to business as usual," said Karel Vuursteen, Chairman of the Supervisory Board.

AkzoNobel will organize an analyst conference call and media interviews on Friday, December 14. Supervisory Board member Antony Burgmans, and CEO Ton Büchner will answer questions relating to this announcement.

On February 20, 2013, AkzoNobel will announce its Q4 and Full Year 2012 results, and Ton Büchner will give the Strategy Update, postponed from October 22.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.